HEADER HYDROLASE 07-SEP-21 7VE2 TITLE CRYSTAL STRUCTURE OF LOPINAVIR BOUND PLASMEPSIN II (PMII) FROM TITLE 2 PLASMODIUM FALCIPARUM COMPND MOL_ID: 1; COMPND 2 MOLECULE: PLASMEPSIN II; COMPND 3 CHAIN: A; COMPND 4 EC: 3.4.23.39; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PLASMODIUM FALCIPARUM (ISOLATE 3D7); SOURCE 3 ORGANISM_TAXID: 36329; SOURCE 4 STRAIN: ISOLATE 3D7; SOURCE 5 GENE: PF3D7_1408000; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: ROSETTA-GAMI B(DE3)PLYSS; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET32B KEYWDS INHIBITOR, PROTEASE, PEPTIDOMIMETIC, HIV-1 PROTEASE INHIBITOR, KEYWDS 2 PEPTIDASE, HEMOGLOBIN DEGRADER, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR V.MISHRA,I.RATHORE,P.BHAUMIK REVDAT 3 06-MAR-24 7VE2 1 JRNL REVDAT 2 29-NOV-23 7VE2 1 REMARK REVDAT 1 01-FEB-23 7VE2 0 JRNL AUTH V.MISHRA,A.DESHMUKH,I.RATHORE,S.CHAKRABORTY,S.PATANKAR, JRNL AUTH 2 A.GUSTCHINA,A.WLODAWER,R.Y.YADA,P.BHAUMIK JRNL TITL INHIBITION OF PLASMODIUM FALCIPARUM PLASMEPSINS BY DRUGS JRNL TITL 2 TARGETING HIV-1 PROTEASE: A WAY FORWARD FOR ANTIMALARIAL JRNL TITL 3 DRUG DISCOVERY. JRNL REF CURR RES STRUCT BIOL V. 7 00128 2024 JRNL REFN ESSN 2665-928X JRNL PMID 38304146 JRNL DOI 10.1016/J.CRSTBI.2024.100128 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH V.MISHRA,I.RATHORE,P.BHAUMIK REMARK 1 TITL MOLECULAR INSIGHTS INTO THE INHIBITION OF PLASMEPSINS BY REMARK 1 TITL 2 HIV-1 PROTEASE INHIBITORS: IMPLICATIONS FOR ANTIMALARIAL REMARK 1 TITL 3 DRUG DISCOVERY. REMARK 1 REF BIORXIV 2023 REMARK 1 REFN ISSN 2692-8205 REMARK 1 DOI 10.1101/2021.09.27.461917 REMARK 2 REMARK 2 RESOLUTION. 3.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0267 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 38.52 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 6531 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.227 REMARK 3 R VALUE (WORKING SET) : 0.225 REMARK 3 FREE R VALUE : 0.266 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 344 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.28 REMARK 3 REFLECTION IN BIN (WORKING SET) : 455 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.3680 REMARK 3 BIN FREE R VALUE SET COUNT : 24 REMARK 3 BIN FREE R VALUE : 0.4240 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2606 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 130 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 87.22 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 127.4 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 5.26000 REMARK 3 B22 (A**2) : 5.26000 REMARK 3 B33 (A**2) : -10.53000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.561 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.637 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 83.027 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.938 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.912 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2813 ; 0.004 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 2625 ; 0.002 ; 0.017 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3847 ; 1.437 ; 1.641 REMARK 3 BOND ANGLES OTHERS (DEGREES): 6082 ; 1.100 ; 1.573 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 328 ; 9.262 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 131 ;38.217 ;24.504 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 437 ;20.908 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 3 ;12.205 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 378 ; 0.057 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3096 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 614 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1315 ; 1.370 ; 4.995 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1314 ; 1.370 ; 4.994 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1642 ; 2.423 ; 7.488 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 1643 ; 2.423 ; 7.489 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1498 ; 1.526 ; 5.774 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 1496 ; 1.522 ; 5.751 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 2206 ; 2.724 ; 8.640 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 11258 ; 6.984 ;98.479 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 11259 ; 6.985 ;98.494 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 3 A 331 REMARK 3 ORIGIN FOR THE GROUP (A): -32.8530 -13.0050 13.9870 REMARK 3 T TENSOR REMARK 3 T11: 0.0423 T22: 0.5863 REMARK 3 T33: 1.3440 T12: -0.1485 REMARK 3 T13: -0.0473 T23: 0.1322 REMARK 3 L TENSOR REMARK 3 L11: 4.8121 L22: 5.4686 REMARK 3 L33: 2.9266 L12: 3.6665 REMARK 3 L13: 0.8592 L23: 0.3776 REMARK 3 S TENSOR REMARK 3 S11: -0.0028 S12: -0.5038 S13: 0.5395 REMARK 3 S21: -0.1372 S22: -0.0022 S23: 1.2695 REMARK 3 S31: 0.3161 S32: -1.2567 S33: 0.0050 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 7VE2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 08-SEP-21. REMARK 100 THE DEPOSITION ID IS D_1300024368. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-MAR-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 6877 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.200 REMARK 200 RESOLUTION RANGE LOW (A) : 38.520 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 7.540 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.9500 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.30 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 7.57 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.040 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5YIC REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.33 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.81 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.4 M AMMONIUM SULFATE, 0.1 M BIS-TRIS REMARK 280 PH 5.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 4 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -Y,X,Z REMARK 290 4555 Y,-X,Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -Y+1/2,X+1/2,Z+1/2 REMARK 290 8555 Y+1/2,-X+1/2,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 54.47000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 54.47000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 35.10000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 54.47000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 54.47000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 35.10000 REMARK 290 SMTRY1 7 0.000000 -1.000000 0.000000 54.47000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 54.47000 REMARK 290 SMTRY3 7 0.000000 0.000000 1.000000 35.10000 REMARK 290 SMTRY1 8 0.000000 1.000000 0.000000 54.47000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 54.47000 REMARK 290 SMTRY3 8 0.000000 0.000000 1.000000 35.10000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1140 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14820 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -4.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LEU A 1 REMARK 465 GLY A 2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG1 THR A 226 OD2 ASP A 295 2.11 REMARK 500 OG SER A 65 OD2 ASP A 91 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 5 168.30 67.75 REMARK 500 GLN A 14 -1.60 72.30 REMARK 500 ASN A 15 -26.46 109.30 REMARK 500 LEU A 55 -1.01 -57.01 REMARK 500 LYS A 57 -167.28 -125.83 REMARK 500 ASP A 91 160.55 161.17 REMARK 500 GLU A 106 122.05 -37.99 REMARK 500 ASN A 111 -55.86 -6.29 REMARK 500 ASN A 149 15.79 58.65 REMARK 500 ALA A 154 49.58 -80.32 REMARK 500 HIS A 163 108.19 -44.02 REMARK 500 ARG A 178 5.44 -56.04 REMARK 500 ASP A 192 22.44 -149.40 REMARK 500 LEU A 208 -44.85 -155.84 REMARK 500 GLU A 209 141.45 61.10 REMARK 500 LYS A 210 74.41 41.35 REMARK 500 ASN A 235 75.28 50.26 REMARK 500 PHE A 243 -19.04 79.70 REMARK 500 ASN A 253 103.93 -39.06 REMARK 500 ASN A 265 -70.18 -80.90 REMARK 500 ILE A 279 41.97 -148.51 REMARK 500 GLU A 280 -38.94 -31.17 REMARK 500 ASN A 290 49.04 -109.54 REMARK 500 ARG A 309 -16.94 -49.58 REMARK 500 GLN A 320 56.58 34.13 REMARK 500 ALA A 327 -179.73 -61.60 REMARK 500 REMARK 500 REMARK: NULL DBREF 7VE2 A 1 331 UNP Q8I6V3 Q8I6V3_PLAF7 123 453 SEQRES 1 A 331 LEU GLY SER SER ASN ASP ASN ILE GLU LEU VAL ASP PHE SEQRES 2 A 331 GLN ASN ILE MET PHE TYR GLY ASP ALA GLU VAL GLY ASP SEQRES 3 A 331 ASN GLN GLN PRO PHE THR PHE ILE LEU ASP THR GLY SER SEQRES 4 A 331 ALA ASN LEU TRP VAL PRO SER VAL LYS CYS THR THR ALA SEQRES 5 A 331 GLY CYS LEU THR LYS HIS LEU TYR ASP SER SER LYS SER SEQRES 6 A 331 ARG THR TYR GLU LYS ASP GLY THR LYS VAL GLU MET ASN SEQRES 7 A 331 TYR VAL SER GLY THR VAL SER GLY PHE PHE SER LYS ASP SEQRES 8 A 331 LEU VAL THR VAL GLY ASN LEU SER LEU PRO TYR LYS PHE SEQRES 9 A 331 ILE GLU VAL ILE ASP THR ASN GLY PHE GLU PRO THR TYR SEQRES 10 A 331 THR ALA SER THR PHE ASP GLY ILE LEU GLY LEU GLY TRP SEQRES 11 A 331 LYS ASP LEU SER ILE GLY SER VAL ASP PRO ILE VAL VAL SEQRES 12 A 331 GLU LEU LYS ASN GLN ASN LYS ILE GLU ASN ALA LEU PHE SEQRES 13 A 331 THR PHE TYR LEU PRO VAL HIS ASP LYS HIS THR GLY PHE SEQRES 14 A 331 LEU THR ILE GLY GLY ILE GLU GLU ARG PHE TYR GLU GLY SEQRES 15 A 331 PRO LEU THR TYR GLU LYS LEU ASN HIS ASP LEU TYR TRP SEQRES 16 A 331 GLN ILE THR LEU ASP ALA HIS VAL GLY ASN ILE MET LEU SEQRES 17 A 331 GLU LYS ALA ASN CYS ILE VAL ASP SER GLY THR SER ALA SEQRES 18 A 331 ILE THR VAL PRO THR ASP PHE LEU ASN LYS MET LEU GLN SEQRES 19 A 331 ASN LEU ASP VAL ILE LYS VAL PRO PHE LEU PRO PHE TYR SEQRES 20 A 331 VAL THR LEU CYS ASN ASN SER LYS LEU PRO THR PHE GLU SEQRES 21 A 331 PHE THR SER GLU ASN GLY LYS TYR THR LEU GLU PRO GLU SEQRES 22 A 331 TYR TYR LEU GLN HIS ILE GLU ASP VAL GLY PRO GLY LEU SEQRES 23 A 331 CYS MET LEU ASN ILE ILE GLY LEU ASP PHE PRO VAL PRO SEQRES 24 A 331 THR PHE ILE LEU GLY ASP PRO PHE MET ARG LYS TYR PHE SEQRES 25 A 331 THR VAL PHE ASP TYR ASP ASN GLN SER VAL GLY ILE ALA SEQRES 26 A 331 LEU ALA LYS LYS ASN LEU HET AB1 A 401 46 HET CPS A 402 42 HET CPS A 403 42 HETNAM AB1 N-{1-BENZYL-4-[2-(2,6-DIMETHYL-PHENOXY)-ACETYLAMINO]-3- HETNAM 2 AB1 HYDROXY-5-PHENYL-PENTYL}-3-METHYL-2-(2-OXO-TETRAHYDRO- HETNAM 3 AB1 PYRIMIDIN-1-YL)-BUTYRAMIDE HETNAM CPS 3-[(3-CHOLAMIDOPROPYL)DIMETHYLAMMONIO]-1- HETNAM 2 CPS PROPANESULFONATE HETSYN AB1 ABT-378; LOPINAVIR HETSYN CPS CHAPS FORMUL 2 AB1 C37 H48 N4 O5 FORMUL 3 CPS 2(C32 H58 N2 O7 S) HELIX 1 AA1 THR A 51 LYS A 57 5 7 HELIX 2 AA2 ASP A 61 SER A 65 5 5 HELIX 3 AA3 TRP A 130 SER A 134 5 5 HELIX 4 AA4 PRO A 140 GLN A 148 1 9 HELIX 5 AA5 GLU A 176 ARG A 178 5 3 HELIX 6 AA6 PRO A 225 GLN A 234 1 10 HELIX 7 AA7 GLU A 271 TYR A 275 1 5 HELIX 8 AA8 GLY A 304 ARG A 309 1 6 SHEET 1 AA1 6 TRP A 43 PRO A 45 0 SHEET 2 AA1 6 LEU A 98 GLY A 112 1 O VAL A 107 N VAL A 44 SHEET 3 AA1 6 THR A 83 VAL A 95 -1 N THR A 83 O GLY A 112 SHEET 4 AA1 6 MET A 17 VAL A 24 -1 N GLU A 23 O THR A 94 SHEET 5 AA1 6 GLN A 29 ASP A 36 -1 O PHE A 31 N ALA A 22 SHEET 6 AA1 6 GLY A 124 GLY A 127 1 O LEU A 126 N ASP A 36 SHEET 1 AA2 9 LYS A 74 ASN A 78 0 SHEET 2 AA2 9 THR A 83 VAL A 95 -1 O VAL A 84 N MET A 77 SHEET 3 AA2 9 MET A 17 VAL A 24 -1 N GLU A 23 O THR A 94 SHEET 4 AA2 9 ASN A 7 PHE A 13 -1 N PHE A 13 O MET A 17 SHEET 5 AA2 9 GLY A 168 THR A 171 -1 O GLY A 168 N LEU A 10 SHEET 6 AA2 9 LEU A 155 TYR A 159 -1 N THR A 157 O THR A 171 SHEET 7 AA2 9 TYR A 311 ASP A 316 -1 O THR A 313 N PHE A 158 SHEET 8 AA2 9 SER A 321 ALA A 327 -1 O GLY A 323 N VAL A 314 SHEET 9 AA2 9 TYR A 180 LYS A 188 -1 N GLU A 181 O LEU A 326 SHEET 1 AA3 4 ILE A 206 MET A 207 0 SHEET 2 AA3 4 GLN A 196 VAL A 203 -1 N VAL A 203 O ILE A 206 SHEET 3 AA3 4 PHE A 259 THR A 262 -1 O THR A 262 N ASP A 200 SHEET 4 AA3 4 LYS A 267 LEU A 270 -1 O TYR A 268 N PHE A 261 SHEET 1 AA4 4 ILE A 206 MET A 207 0 SHEET 2 AA4 4 GLN A 196 VAL A 203 -1 N VAL A 203 O ILE A 206 SHEET 3 AA4 4 ALA A 211 ILE A 214 -1 O ALA A 211 N LEU A 199 SHEET 4 AA4 4 THR A 300 ILE A 302 1 O PHE A 301 N ILE A 214 SHEET 1 AA5 2 ILE A 222 VAL A 224 0 SHEET 2 AA5 2 ILE A 291 GLY A 293 1 O ILE A 292 N VAL A 224 SHEET 1 AA6 4 ILE A 239 LYS A 240 0 SHEET 2 AA6 4 TYR A 247 LEU A 250 -1 O VAL A 248 N ILE A 239 SHEET 3 AA6 4 LEU A 286 LEU A 289 -1 O CYS A 287 N THR A 249 SHEET 4 AA6 4 LEU A 276 HIS A 278 -1 N GLN A 277 O MET A 288 SSBOND 1 CYS A 49 CYS A 54 1555 1555 2.03 SSBOND 2 CYS A 251 CYS A 287 1555 1555 2.06 CISPEP 1 GLU A 114 PRO A 115 0 8.77 CRYST1 108.940 108.940 70.200 90.00 90.00 90.00 I 4 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009179 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009179 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014245 0.00000